Originalkatalog | Verfügbarkeit prüfen

EE309 Cost-Effectiveness of Mavacamten for the Treatment of Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy in the Netherlands

Buisman, L., Treur, M., Verkaik, M., Van De Wetering, G., Pronk, L.M., Pompen, M., Hurst, M.
Veröffentlicht in: Value in Health ; volume 26, issue 12, page S110 ; ISSN 1098-3015;
2023